LIMITED STOCK AVAILABLEPRICES SHOWN WHERE AVAILABLE
THYMOSIN ALPHA-1

RECOVERY / SINGLE

THYMOSIN ALPHA-1

5MG · 10MG
Important medical and research notice

This content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.

Research Overview

A thymic peptide studied in immune-signalling research, particularly T-cell maturation and dendritic-cell function.

Available Strengths

  • 5MG (TA5)
  • 10MG (TA10)

Research Protocol

Reference schedule

PeriodDoseU-100 unitsVolume
Week 10.3 mg180.18 mL
Weeks 2–80.5 mg300.3 mL

Reconstitution

Water volume3 mLConcentration1.67 mg/mLAdministrationSubcutaneousFrequencyOnce dailyCycle length8–12 weeks in the reference protocol, optionally extended to 16 weeks.

≈1.67 mg/mL once reconstituted

  1. Draw 3.0 mL of bacteriostatic water per 5 mg vial.
  2. Inject slowly along the vial wall; swirl gently until dissolved.

Research context

Discussed as enhancing T-cell maturation and differentiation, augmenting dendritic-cell function, and promoting interferon-α and interleukin-2 production in immune research.

Storage

2–8°C short-term or −20°C long-term. 2–8°C, use within 7 days, avoid freeze-thaw cycles.

Research Notes

  • For educational and research reference only. Not medical advice and not intended for unsupervised human use.

References

Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source